# Calcagno, Frank A. MD – FDA Inspection, Apr 30, 2018

Source: https://www.keypedia.com/records/fda_inspections/calcagno-frank-a-md/de5f2737-a1f7-407d-b1fd-531be1ca662b
Source feed: FDA_Inspections

> FDA inspection 1050172 of Calcagno, Frank A. MD, April 30, 2018. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050172
- Company Name: Calcagno, Frank A. MD
- Inspection Date: 2018-04-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 891118 - 2014-08-13

## Related Officers

- [Company Rep](https://www.keypedia.com/people/sherri-n-rohlf/41090ab1-83d1-4e95-92ea-0cfca5cecdb6)

Company: https://www.keypedia.com/companies/calcagno-frank-a-md/0b6a25b5-9463-4476-a04f-3dd6913c6bef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c